Should I buy Amphenol (APH) stock or is it too late?
⭐ The most reliable of them, either direction: Truist Securities — 74% of its targets hit on this sector (203 calls tested). It aims for $215 (+33 %), call made on July 31, 2026, maturing on July 31, 2027 (28 d ago).
Firm-by-firm track record on Amphenol
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Baird | 100 % | +60.5 % | 13 | $139 -14% |
| Truist Securities | 100 % | +56.3 % | 10 | $215 +33% |
| JP Morgan | 100 % | +55.3 % | 9 | $200 +24% |
| UBS | 100 % | +49.9 % | 11 | $197 +22% |
| Goldman Sachs | 80 % | +48.6 % | 10 | $154 -5% |
| Citigroup | 100 % | +48.6 % | 14 | $210 +30% |
| Evercore ISI Group | 100 % | +46.6 % | 8 | $180 +12% |
| B of A Securities | 100 % | +37.4 % | 6 | $185 +15% |
✅ Reasons to believe
- 90% of analysts rate it a buy (Buy consensus, 10 ratings) — a sign of market conviction.
- Median price target $199, i.e. +23% from the current price ($161).
- 5 analysts rated reliable (≥55% hit rate, beat their sector) are bullish on the stock.
⚠️ Reasons to hesitate
- Even the most reliable firm on APH, Baird (100% hit rate, 13 scored calls), only targets $139 (call made on October 10, 2025, maturing on October 10, 2026) (-14%) in its most recent call. The stock may already have run past its target.
- The consensus is not unanimous: of 10 ratings, 1 is neutral.
- High valuation (P/E ~40): strong growth is already "priced in", leaving little room for error.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- Volatile stock: sharp swings — including steep drops — are part of its profile.
The analyst consensus on APH
Median target $199 (+23%) · 10 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Amphenol now?
We won't decide for you. The facts: 90% of analysts rate it a buy, median target $199 (+23%), and Baird (most reliable on APH, 100%) targets $139. Weigh that against valuation (P/E ~40) and volatility. This is not personalized advice.
Is it too late to invest in Amphenol?
Not according to analysts: the median target ($199) is still +23% above the current price ($161) (most reliable on APH: Baird, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Amphenol still worth investing in?
It depends on the gap between the price ($161) and its estimated value: analysts target $199 on median (+23%), with 90% buys (most reliable on APH: Baird, 100%). Cross-check with their real reliability on APH and the cautions above. Information, not advice.
What's the main risk in buying APH?
Even the most reliable firm on APH, Baird (100% hit rate, 13 scored calls), only targets $139 (call made on October 10, 2025, maturing on October 10, 2026) (-14%) in its most recent call. The stock may already have run past its target.
→ Go deeper: the full Amphenol profile (consensus, analyst reliability, price target, performance).